BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7673495)

  • 1. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America.
    Dillon WI; Saed GM; Fivenson DP
    J Am Acad Dermatol; 1995 Oct; 33(4):617-20. PubMed ID: 7673495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients.
    Fujiwara H; Fujiwara K; Hashimoto K; Mehregan AH; Schaumburg-Lever G; Lange R; Schempp C; Gollnick H
    Arch Dermatol; 1997 Jan; 133(1):41-4. PubMed ID: 9006371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification.
    Schempp C; Bocklage H; Lange R; Kölmel HW; Orfanos CE; Gollnick H
    J Invest Dermatol; 1993 May; 100(5):717-20. PubMed ID: 8491994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases.
    De Vito JR; Merogi AJ; Vo T; Boh EE; Fung HK; Freeman SM; Cockerell C; Stewart K; Marrogi AJ
    J Cutan Pathol; 1996 Aug; 23(4):350-8. PubMed ID: 8864923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus.
    Ozkan S; Atabey N; Fetil E; Erkizan V; Günes AT
    Int J Dermatol; 2000 Apr; 39(4):278-83. PubMed ID: 10809977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review.
    Alonso-Llamazares J; Persing DH; Anda P; Gibson LE; Rutledge BJ; Iglesias L
    Acta Derm Venereol; 1997 Jul; 77(4):299-304. PubMed ID: 9228224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.
    Ranki A; Aavik E; Peterson P; Schauman K; Nurmilaakso P
    J Invest Dermatol; 1994 Mar; 102(3):339-45. PubMed ID: 8120417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is morphoea caused by Borrelia burgdorferi? A review.
    Weide B; Walz T; Garbe C
    Br J Dermatol; 2000 Apr; 142(4):636-44. PubMed ID: 10792212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR-based study and review of the literature.
    Zollinger T; Mertz KD; Schmid M; Schmitt A; Pfaltz M; Kempf W
    J Cutan Pathol; 2010 May; 37(5):571-7. PubMed ID: 20015188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus.
    Ross SA; Sánchez JL; Taboas JO
    Am J Dermatopathol; 1990 Aug; 12(4):357-62. PubMed ID: 2393064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma.
    Wienecke R; Schlüpen EM; Zöchling N; Neubert U; Meurer M; Volkenandt M
    J Invest Dermatol; 1995 Jan; 104(1):23-6. PubMed ID: 7798636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States.
    Colomé-Grimmer MI; Payne DA; Tyring SK; Sánchez RL
    Arch Dermatol; 1997 Sep; 133(9):1174. PubMed ID: 9301604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Borrelia burgdorferi antibodies in scleroderma circumscripta, lichen sclerosus et atrophicus, erythema nodosum, granuloma annulare, erythema annulare and chronic urticaria].
    Svecova D; Buchvald J
    Bratisl Lek Listy; 2000; 101(4):194-9. PubMed ID: 10914463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus.
    Eisendle K; Grabner T; Kutzner H; Zelger B
    Arch Dermatol; 2008 May; 144(5):591-8. PubMed ID: 18490585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG antibody reactivity to Borrelia burgdorferi sensu stricto antigens in patients with morphea in Colombia.
    Palacios R; Torres A; Trujillo R
    Int J Dermatol; 2003 Nov; 42(11):882-6. PubMed ID: 14636204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and genotyping of Borrelia burgdorferi sensu lato by polymerase chain reaction.
    Situm M; Grahovac B; Marković S; Lipozencić J; Poje G; Dobrić I; Marinović B; Bolanca-Bumber S; Misić-Majerus L
    Croat Med J; 2000 Mar; 41(1):47-53. PubMed ID: 10810167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea).
    Fan W; Leonardi CL; Penneys NS
    J Am Acad Dermatol; 1995 Oct; 33(4):682-4. PubMed ID: 7673508
    [No Abstract]   [Full Text] [Related]  

  • 19. Solitary erythema migrans in Georgia and South Carolina.
    Felz MW; Chandler FW; Oliver JH; Rahn DW; Schriefer ME
    Arch Dermatol; 1999 Nov; 135(11):1317-26. PubMed ID: 10566829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding spectrum of cutaneous borreliosis.
    Eisendle K; Zelger B
    G Ital Dermatol Venereol; 2009 Apr; 144(2):157-71. PubMed ID: 19357623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.